Viewing Study NCT06798961


Ignite Creation Date: 2025-12-24 @ 1:01 PM
Ignite Modification Date: 2025-12-30 @ 8:38 PM
Study NCT ID: NCT06798961
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-14
First Post: 2025-01-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)
Sponsor: United States Naval Medical Center, San Diego
Organization:

Study Overview

Official Title: Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: LEAD-AP
Brief Summary: The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.
Detailed Description: The LEAD-AP study is a dual arm retrospective observational cohort study (using existing records) to investigate the long-term outcomes of patients diagnosed with an accessory pathway during their military service.

Overall objective: Identifying additional risk factors associated with sudden cardiac death to help with risk stratification and guide ablation criteria for patients diagnosed with accessory pathways between the ages of 18-40.

Specific Aim/Research Question: The investigators will evaluate whether patients with an ablation have improved outcomes.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: